BamSEC and AlphaSense Join Forces
Learn More

Viridian Therapeutics Inc. – Indentures

NASDAQ: VRDN    
Share price (5/22/26): $17.24    
Market cap (5/22/26): $1.777 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 8-K 98 pages Viridian Therapeutics, Inc. and U.S. Bank Trust Company, National Association as Trustee First Supplemental Indenture Dated as of May 11, 2026 1.75% Convertible Senior Notes Due 2032 Cross Reference Table*
12/34/56
EX-4.1
from 8-K 39 pages Viridian Therapeutics, Inc. and U.S. Bank Trust Company, National Association, as Trustee Indenture Dated as of May 11, 2026
12/34/56
EX-4.5
from 10-K 6 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.5
from 10-K 6 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from S-3ASR 15 pages Form of Registration Rights Agreement
12/34/56
EX-4.5
from 10-K 5 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from S-3ASR 42 pages Definitions and Incorporation by Reference
12/34/56
EX-4.5
from S-3 42 pages Definitions and Incorporation by Reference
12/34/56
EX-4.5
from 10-K 5 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.5
from S-3 20 pages Miragen Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Miragen Therapeutics, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.3
from S-3 58 pages Miragen Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20__ Debt Securities
12/34/56
EX-4.5
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 24 pages Form of Warrant Miragen Therapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 14 pages Registration Rights Agreement
12/34/56
EX-4.2
from 10-K 16 pages Warrant to Purchase Stock
12/34/56
EX-4.5
from S-3 23 pages Miragen Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Miragen Therapeutics, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.3
from S-3 55 pages Miragen Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of Debt Securities
12/34/56
EX-4.4
from S-3 50 pages Signal Genetics, Inc. Indenture Dated as of [ ], 20[ ] [ ] Trustee
12/34/56
EX-4.2
from S-1/A 13 pages Form of Representative’s Warrant Agreement
12/34/56
EX-4.6
from S-8 8 pages Signal Genetics, Inc. Restricted Stock Unit Grant Agreement Under the 2014 Stock Incentive Plan
12/34/56